Serveur d'exploration sur le lymphœdème - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « Mass drug administration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masquelet < Mass drug administration < Mass screening  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000212 (2017) Clarer Jones [Tanzanie] ; Billy Ngasalla [Tanzanie] ; Yahya A. Derua [Tanzanie] ; Donath Tarimo [Tanzanie] ; Mwelecele N. Malecela [Tanzanie]Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
000243 (2017) Tammy Allen ; Fasihah Taleo [Vanuatu] ; Patricia M. Graves ; Peter Wood ; George Taleo [Vanuatu] ; Margaret C. Baker [États-Unis] ; Mark Bradley [Royaume-Uni] ; Kazuyo Ichimori [Japon]Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
000351 (2017) Brent C. Thomas [Royaume-Uni] ; Karsor Kollie [Liberia] ; Benjamin Koudou [Royaume-Uni] ; Charles Mackenzie [Royaume-Uni]Commentary: restarting NTD programme activities after the Ebola outbreak in Liberia
000387 (2017) Abdullah S. Ali [Tanzanie] ; Narjis G. Thawer [Tanzanie] ; Bakar Khatib [Tanzanie] ; Haji H. Amier [Tanzanie] ; Joseph Shija [Tanzanie] ; Mwinyi Msellem [Tanzanie] ; Abdul-Wahid Al-Mafazy [Tanzanie] ; Issa A. Garimo [Tanzanie] ; Humphrey Mkali [Tanzanie] ; Mahdi M. Ramsan [Tanzanie] ; Jessica M. Kafuko [Nigeria] ; Lynn A. Paxton [Tanzanie] ; Richard Reithinger [États-Unis] ; Jeremiah M. Ngondi [Tanzanie]Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar
000423 (2017) Adam Silumbwe [Zambie] ; Joseph Mumba Zulu [Zambie] ; Hikabasa Halwindi [Zambie] ; Choolwe Jacobs [Zambie] ; Jessy Zgambo [Zambie] ; Rosalia Dambe [Zambie] ; Mumbi Chola [Zambie] ; Gershom Chongwe [Zambie] ; Charles Michelo [Zambie]A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa
000448 (2017) Emmanuel Igwaro Odongo-Aginya [Ouganda] ; Alex Olia [Ouganda] ; Kilama Justin Luwa [Ouganda] ; Eiji Nagayasu [Japon] ; Anna Mary Auma [Ouganda] ; Geoffrey Egitat [Ouganda] ; Gerald Mwesigwa [Ouganda] ; Yoshitaka Ogino ; Eisaku Kimura ; Toshihiro HoriiWuchereria bancrofti infection at four primary schools and surrounding communities with no previous blood surveys in northern Uganda: the prevalence after mass drug administrations and a report on suspected non-filarial endemic elephantiasis
000924 (2016) Edwin Michael [États-Unis] ; Brajendra K. Singh [États-Unis]Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis
000F35 (2015) T. Déirdre Hollingsworth ; Emily R. Adams ; Roy M. Anderson ; Katherine Atkins ; Sarah Bartsch [États-Unis] ; María-Gloria Basá Ez ; Matthew Behrend [États-Unis] ; David J. Blok [Pays-Bas] ; Lloyd A. C. Chapman ; Luc Coffeng [Pays-Bas] ; Orin Courtenay ; Ron E. Crump ; Sake J. De Vlas [Pays-Bas] ; Andy Dobson [États-Unis] ; Louise Dyson ; Hajnal Farkas ; Alison P. Galvani [États-Unis] ; Manoj Gambhir ; David Gurarie [États-Unis] ; Michael A. Irvine ; Sarah Jervis ; Matt J. Keeling ; Louise Kelly-Hope ; Charles King [États-Unis] ; Bruce Y. Lee [États-Unis] ; Epke A. Le Rutte [Pays-Bas] ; Thomas M. Lietman [États-Unis] ; Martial Ndeffo-Mbah [États-Unis] ; Graham F. Medley ; Edwin Michael [États-Unis] ; Abhishek Pandey [États-Unis] ; Jennifer K. Peterson [États-Unis] ; Amy Pinsent ; Travis C. Porco [États-Unis] ; Jan Hendrik Richardus [Pays-Bas] ; Lisa Reimer ; Kat S. Rock ; Brajendra K. Singh [États-Unis] ; Wilma Stolk [Pays-Bas] ; Subramanian Swaminathan [Inde] ; Steve J. Torr ; Jeffrey Townsend [États-Unis] ; James Truscott ; Martin Walker ; Alexandra ZouevaQuantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases
001475 (2015) Brajendra K. Singh [États-Unis] ; Edwin Michael [États-Unis]Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis
001494 (2015) Bernard L. Kouassi [Suisse] ; Dziedzom K. De Souza [Ghana] ; Andre Goepogui [Guinée] ; Charles A. Narh [Ghana] ; Sandra A. King [Ghana] ; Baldé S. Mamadou [Guinée] ; Lamia Diakité [Guinée] ; Samuel K. Dadzie [Ghana] ; Daniel A. Boakye [Ghana] ; Jürg Utzinger [Suisse] ; Moses J. Bockarie [Royaume-Uni] ; Benjamin G. Koudou [Royaume-Uni]Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea
001497 (2015) Neal D. E. AlexanderAre we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
001569 (2015) Thishan C. Yahathugoda [Sri Lanka] ; Taniawati Supali [Indonésie] ; Ramakrishna U. Rao [États-Unis] ; Yenny Djuardi [Indonésie] ; Difa Stefani [Indonésie] ; Femmy Pical [Indonésie] ; Peter U. Fischer [États-Unis] ; Melanie M. Lloyd [États-Unis] ; Prasad H. Premaratne [Sri Lanka] ; Mirani V. Weerasooriya [Sri Lanka] ; Gary J. Weil [États-Unis]A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration
001979 (2014) David H. Molyneux ; Adrian Hopkins [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Louise A. Kelly-HopeMultidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms
001A12 (2014) Mohammad A. Hussain [Australie] ; Ashok K. Sitha [Inde] ; Subhashisa Swain [Inde] ; Shridhar Kadam [Inde] ; Sanghamitra Pati [Inde]Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
001A31 (2014) Nazeh M. Al-Abd [Malaisie] ; Zurainee Mohamed Nor [Malaisie] ; Abdulhamid Ahmed ; Abdulelah H. Al-Adhroey [Malaisie] ; Marzida Mansor [Malaisie] ; Mustafa Kassim [Malaisie]Lymphatic filariasis in Peninsular Malaysia: a cross-sectional survey of the knowledge, attitudes, and practices of residents
001A32 (2014) Paul E. Simonsen [Danemark] ; Yahya A. Derua [Tanzanie] ; Stephen M. Magesa [Tanzanie] ; Erling M. Pedersen [Danemark] ; Anna-Sofie Stensgaard [Danemark] ; Mwelecele N. Malecela [Tanzanie] ; William N. Kisinza [Tanzanie]Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
001D98 (2014) Natalie J. Dial [États-Unis] ; Serign J. Ceesay [Gambie] ; Roly D. Gosling [États-Unis] ; Umberto D Lessandro [Gambie] ; Kimberly A. Baltzell [États-Unis]A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia
002097 (2013) Daniel Engelman [Australie] ; Diana L. Martin [États-Unis] ; Roderick J. Hay [Royaume-Uni] ; Olivier Chosidow [France] ; James S. Mccarthy [Australie] ; L Claire Fuller [Royaume-Uni] ; Andrew C. Steer [Australie]Opportunities to investigate the effects of ivermectin mass drug administration on scabies
002192 (2013) Patricia M. Graves [Australie] ; Leo Makita [Papouasie-Nouvelle-Guinée] ; Melinda Susapu [Papouasie-Nouvelle-Guinée] ; Molly A. Brady [Philippines] ; Wayne Melrose [Australie] ; Corinne Capuano [Philippines] ; Zaixing Zhang [Papouasie-Nouvelle-Guinée] ; Luo Dapeng [Papouasie-Nouvelle-Guinée] ; Masayo Ozaki [États-Unis] ; David Reeve [Australie] ; Kazuyo Ichimori [Suisse] ; Walter M. Kazadi [Papouasie-Nouvelle-Guinée] ; Frederick Michna [Australie] ; Moses J. Bockarie ; Louise A. Kelly-HopeLymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
002411 (2013) Rabindra Nath Roy ; Aditya Prasad Sarkar ; Raghunath Misra ; Amitava Chakroborty ; Tusar Kanti Mondal ; Kanad BagCoverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
002462 (2013) Louise A. Kelly-Hope [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni]Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "Mass drug administration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "Mass drug administration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    Mass drug administration
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024